Usoa E Busto
Overview
Explore the profile of Usoa E Busto including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
18
Citations
745
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Selby P, Andriash K, Zawertailo L, Persad D, Zack M, Busto U
J Clin Psychopharmacol
. 2013 Aug;
33(5):667-74.
PMID: 23963055
Fixed-dose nicotine replacement therapy (NRT) is efficacious for smoking cessation in the general population of smokers. However, it is less effective in populations with psychiatric comorbidities and/or severe tobacco dependence...
2.
Sotomayor-Zarate R, Gysling K, Busto U, Cassels B, Tampier L, Quintanilla M
Psychopharmacology (Berl)
. 2013 Jan;
227(2):287-98.
PMID: 23344555
Rationale: Neuronal nicotinic acetylcholine receptors (nAChRs) are pharmacological targets that have recently been implicated in the reinforcing effects of many drugs of abuse, including ethanol. Varenicline and cytisine are nAChR...
3.
Effects of stress and alcohol cues in men with and without problem gambling and alcohol use disorder
Steinberg L, Tremblay A, Zack M, Busto U, Zawertailo L
Drug Alcohol Depend
. 2011 Jun;
119(1-2):46-55.
PMID: 21658863
Background: Relapse is a serious challenge in problem gambling (PG), as it is in substance addiction. Stress and cues are implicated in relapse in both conditions. However, experimental research on...
4.
Zack M, Woodford T, Tremblay A, Steinberg L, Zawertailo L, Busto U
Neuropsychopharmacology
. 2010 Oct;
36(2):445-58.
PMID: 20927046
Stress, cues, and pharmacological priming are linked with relapse to addictive behavior. Increased salience and decreased inhibitory control are thought to mediate the effects of relapse-related stimuli. However, the functional...
5.
Busto A, Souza R, Lobo D, Shaikh S, Zawertailo L, Busto U, et al.
Prog Neuropsychopharmacol Biol Psychiatry
. 2010 Apr;
34(6):834-6.
PMID: 20362026
Studies have shown a genetic susceptibility to develop schizophrenia, alcohol use disorders and nicotine dependence. Brain areas related to reward and reinforcement show high expression of the cocaine and amphetamine...
6.
Yasseen B, Kennedy J, Zawertailo L, Busto U
Psychiatry Res
. 2010 Jan;
176(1):30-3.
PMID: 20071033
Bipolar disorder is a chronic mental illness with high prevalence of co-occurring alcohol use disorder. Linkage studies have revealed several candidate genes in the dopaminergic and serotonergic pathways which may...
7.
Busto U, Redden L, Mayberg H, Kapur S, Houle S, Zawertailo L
Synapse
. 2009 Apr;
63(8):681-9.
PMID: 19360907
Tobacco dependence is highly prevalent in depressed patients. We assessed changes in [(11)C]-raclopride binding potential (BP) using positron emission tomography (PET) before and after the oral administration of d-amphetamine in...
8.
Lanctot K, Herrmann N, Black S, Ryan M, Rothenburg L, Liu B, et al.
Am J Geriatr Psychiatry
. 2008 Jul;
16(7):551-7.
PMID: 18591575
Objective: To assess the role of the dopaminergic brain reward system (BRS) in apathy associated with Alzheimer disease (AD). Design: BRS function was probed in 20 AD patients using dextroamphetamine...
9.
Herrmann N, Rothenburg L, Black S, Ryan M, Liu B, Busto U, et al.
J Clin Psychopharmacol
. 2008 May;
28(3):296-301.
PMID: 18480686
Apathy is a common behavioral symptom of Alzheimer's disease (AD), being present in up to 70% of patients. Apathy in AD and non-AD populations has been associated with dysfunction in...
10.
Glass J, Sproule B, Herrmann N, Busto U
J Clin Psychopharmacol
. 2008 Mar;
28(2):182-8.
PMID: 18344728
A randomized, controlled, crossover clinical study compared 14-night treatment with 15 mg temazepam, 50 mg diphenhydramine, and placebo in elderly individuals with insomnia (mean age, 73.9 years; range, 70-89 years)....